These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38517294)

  • 1. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.
    Han JL; Zimmerer JM; Zeng Q; Chaudhari S; Satoskar A; Abdel-Rasoul M; Uwase H; Breuer CK; Bumgardner GL
    J Immunol; 2024 May; 212(9):1504-1518. PubMed ID: 38517294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-suppressor CXCR5
    Zimmerer JM; Han JL; Peterson CM; Zeng Q; Ringwald BA; Cassol C; Chaudhari S; Hart M; Hemminger J; Satoskar A; Abdel-Rasoul M; Wang JJ; Warren RT; Zhang ZJ; Breuer CK; Bumgardner GL
    Am J Transplant; 2022 Jun; 22(6):1550-1563. PubMed ID: 35114045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition.
    Han JL; Zimmerer JM; Zeng Q; Chaudhari SR; Hart M; Satoskar AA; Abdel-Rasoul M; Breuer CK; Bumgardner GL
    Transplantation; 2024 Mar; 108(3):679-692. PubMed ID: 37872660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
    Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-suppressor CD8+ T Cells Require CXCR5.
    Zimmerer JM; Ringwald BA; Elzein SM; Avila CL; Warren RT; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2019 Sep; 103(9):1809-1820. PubMed ID: 30830040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
    Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3038. PubMed ID: 30728823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.
    Zimmerer JM; Pham TA; Sanders VM; Bumgardner GL
    J Immunol; 2010 Dec; 185(12):7285-92. PubMed ID: 21084663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.
    Gaughan A; Wang J; Pelletier RP; Nadasdy T; Brodsky S; Roy S; Lodder M; Bobek D; Mofatt-Bruce S; Fairchild RL; Henry ML; Hadley GA
    Am J Transplant; 2014 Feb; 14(2):284-94. PubMed ID: 24410909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.
    Zimmerer JM; Pham TA; Wright CL; Tobin KJ; Sanghavi PB; Elzein SM; Sanders VM; Bumgardner GL
    Am J Transplant; 2014 Feb; 14(2):295-304. PubMed ID: 24472191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.
    Horne PH; Lunsford KE; Walker JP; Koester MA; Bumgardner GL
    Cell Transplant; 2008; 17(7):829-44. PubMed ID: 19044209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
    Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Jayashankar K; Garcia SF; Abdel-Rasoul M; van Rooijen N; Bumgardner GL
    Cell Transplant; 2013; 22(7):1157-69. PubMed ID: 23069206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells.
    Dai Z; Zhang S; Xie Q; Wu S; Su J; Li S; Xu Y; Li XC
    Am J Transplant; 2014 Jan; 14(1):39-48. PubMed ID: 24219162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+ T Cells With De Novo DSA Production in the First Year After Kidney Transplant.
    Zimmerer JM; Basinger MW; Ringwald BA; Abdel-Rasoul M; Pelletier RP; Rajab A; El-Hinnawi A; Parekh H; Washburn K; Bumgardner GL
    Transplantation; 2020 Nov; 104(11):2424-2434. PubMed ID: 32032292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.
    Zimmerer JM; Liu XL; Blaszczak A; Avila CL; Pham TA; Warren RT; Bumgardner GL
    J Immunol; 2018 Dec; 201(12):3731-3740. PubMed ID: 30397035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.